ASPEN PHARMACARE HOLDINGS LIMITED - PRESS RELEASE
ISIN CODE: ZAE000023586
SHARE CODE: APN
Aspen Pharmacare Holdings Limited ("Aspen") has entered into a transaction to
acquire Triomed (Pty) Ltd ("Triomed") for R50 million. The transaction is
subject to the fulfillment of certain conditions and is currently under
consideration by the Competition Commission. Triomed markets and distributes
pharmaceuticals in the over the counter and generic market sectors in South
Africa. Its product range complements Aspen`s existing product portfolio.
As reported previously by Aspen, the South African Revenue Services ("SARS") had
raised a tax assessment in respect of a transaction entered into by Pharmacare
Limited ("Pharmacare") prior to the acquisition of that company by Aspen.
Subsequent to the publication by Aspen on 21 August 2002 of its preliminary
financial results announcement, SARS has formally notified Aspen that the appeal
against the additional assessment referred to above has been conceded in favour
of Pharmacare. SARS has issued a revised assessment.
More information on these items is available in the Aspen annual report posted
to shareholders today.
Date: 30/10/2002 01:43:00 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
